Trial · NCT03019406
Participant flow28
How many started, completed or left each group, period by period.
1 to 20 of 28
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| PAP: up to 25 Weeks | STARTED | Cohort 1: Avalglucosidase Alfa 20 mg/kg | 6 | |
| PAP: up to 25 Weeks | STARTED | Cohort 2: Avalglucosidase Alfa 40 mg/kg | 5 | |
| PAP: up to 25 Weeks | STARTED | Cohort 3a: Avalglucosidase Alfa 40 mg//kg | 5 | |
| PAP: up to 25 Weeks | STARTED | Cohort 3b: Alglucosidase Alfa in PAP | 6 | |
| PAP: up to 25 Weeks | Treated | Cohort 1: Avalglucosidase Alfa 20 mg/kg | 6 | |
| PAP: up to 25 Weeks | Treated | Cohort 2: Avalglucosidase Alfa 40 mg/kg | 5 | |
| PAP: up to 25 Weeks | Treated | Cohort 3a: Avalglucosidase Alfa 40 mg//kg | 5 | |
| PAP: up to 25 Weeks | Treated | Cohort 3b: Alglucosidase Alfa in PAP | 6 | |
| PAP: up to 25 Weeks | COMPLETED | Cohort 1: Avalglucosidase Alfa 20 mg/kg | 6 | |
| PAP: up to 25 Weeks | COMPLETED | Cohort 2: Avalglucosidase Alfa 40 mg/kg | 5 | |
| PAP: up to 25 Weeks | COMPLETED | Cohort 3a: Avalglucosidase Alfa 40 mg//kg | 5 | |
| PAP: up to 25 Weeks | COMPLETED | Cohort 3b: Alglucosidase Alfa in PAP | 6 | |
| PAP: up to 25 Weeks | NOT COMPLETED | Cohort 1: Avalglucosidase Alfa 20 mg/kg | 0 | |
| PAP: up to 25 Weeks | NOT COMPLETED | Cohort 2: Avalglucosidase Alfa 40 mg/kg | 0 | |
| PAP: up to 25 Weeks | NOT COMPLETED | Cohort 3a: Avalglucosidase Alfa 40 mg//kg | 0 | |
| PAP: up to 25 Weeks | NOT COMPLETED | Cohort 3b: Alglucosidase Alfa in PAP | 0 | |
| ETP: Ongoing From Week 26 | STARTED | Cohort 1: Avalglucosidase Alfa 20 mg/kg | 6 | |
| ETP: Ongoing From Week 26 | STARTED | Cohort 2: Avalglucosidase Alfa 40 mg/kg | 5 | |
| ETP: Ongoing From Week 26 | STARTED | Cohort 3a: Avalglucosidase Alfa 40 mg//kg | 5 | |
| ETP: Ongoing From Week 26 | STARTED | Cohort 3b: Alglucosidase Alfa in PAP | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03019406/flow